Basic & Clinical Medicine ›› 2022, Vol. 42 ›› Issue (9): 1350-1354.doi: 10.16352/j.issn.1001-6325.2022.09.1350

• Original Articles • Previous Articles     Next Articles

Circ_0032821 is involved in sorafenib's inhibition of the proliferation, migration and invasion of breast cancer cell line T47D

ZHANG Xiao-lei1*, LIU Jing2, LI Chao-ping3   

  1. 1. Department of Breast Surgery, Sanmenxia Hospital of Yellow River, Sanmenxia 472000;
    2. Department of Health Examination, Sanmenxia Hospital of Yellow River, Sanmenxia 472000;
    3. Department of Cancer Center, Luoyang Central Hospital Affiliated to Zhengzhou University, Luoyang 471000, China
  • Received:2021-06-11 Revised:2021-12-13 Online:2022-09-05 Published:2022-09-02

Abstract: Objective To investigate the effect and possible mechanism of sorafenib on the proliferation, migration and invasion of breast cancer cell line T47D. Methods Effects of sorafenib (2.5, 5 and 10 μmol/L) on T47D cells proliferation, colony formation, migration and invasion were detected by CCK-8 experiment, plate cloning experiment, scratch healing experiment and Transwell experiment. RT-qPCR was applied to detect circ_0032821 expression. The circ_0032821 small interfering RNA(si-circ_0032821) and circ_0032821 over-expression plasmid were transfected into T47D cells respectively. And the effect of interference with circ_0032821 or circ_0032821 over-expression combined with sorafenib on the malignant behavior of T47D cells was detected. Results The cell proliferation inhibition rate T47D cells were significantly increased after sorafenib treatment (P<0.05); The colony formation number, scratch healing rate, invasion number, and circ_0032821 expression were significantly decreased(P<0.05).After silencing with the expression of circ_0032821, the proliferation inhibition rate of T47D cells was significantly increased (P<0.05); The colony formation number, scratch healing rate and invasion number were significantly reduced(P<0.05). Circ_0032821 over-expression significantly reduced the effects of sorafenib on the proliferation, migration colony formation and invasion of T47D cells (P<0.05). Conclusions Sorafenib can inhibit T47D cell proliferation, migration and invasion. And the mechanism may be explained by the down-regulation of circ_0032821.

Key words: sorafenib, breast cancer, proliferation, migration, circ_0032821

CLC Number: